Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Sean Toomey

Orthopaedic Surgery Seattle, WA Medical Doctor

NPI 1003876343 CMS profile 90831

601 Broadway, Seattle, WA 98122

Open in the dashboard

General payments

$1,185,645

1,036 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$92,764 paid to institutions, not to them · program years 2019–2024

Through program year 2025, Sean Toomey of Seattle, WA is reported in the CMS Open Payments database as having received $1,185,645 across 1,036 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $92,764 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 98th percentile of Orthopaedic Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $94,154 63
2024 General $14,817 15
2023 General $196,369 184
2022 General $272,518 292
2021 General $164,106 160
2020 General $157,134 131
2019 General $286,548 191

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Sean Toomey
  • Orthopaedic Surgery median
  • Middle half of Orthopaedic Surgery
  • National median

In program year 2025, general payments to Sean Toomey were reported at $94,154. Among 15,343 Orthopaedic Surgery profiles paid that year, the median was $563 and the middle half received between $147 and $2,717.

Show as a table
Year Sean Toomey Orthopaedic Surgery median Middle half National median
2019 $286,548 $644 $140–$2,844 $163
2020 $157,134 $312 $75–$1,860 $114
2021 $164,106 $520 $117–$2,495 $132
2022 $272,518 $598 $128–$2,731 $149
2023 $196,369 $461 $128–$2,264 $160
2024 $14,817 $497 $134–$2,475 $164
2025 $94,154 $563 $147–$2,717 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Stryker Corporation $1,184,736 1,027 payments
  2. Davol Inc. $514 3 payments
  3. Becton, Dickinson and Company $164 1 payment
  4. DePuy Synthes Sales Inc. $107 1 payment
  5. Medacta USA, Inc. $59 1 payment
  6. TerSera Therapeutics LLC $32 1 payment
  7. Radius Health, Inc. $18 1 payment
  8. Ethicon US, LLC $15 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $1,017,202 237 payments
  2. Travel and Lodging $143,013 337 payments
  3. Food and Beverage $25,431 462 payments
Products named General payments · program years 2019–2025
  1. MAKO Knees, Hips $683,723 647 payments
  2. MAKO Knees, Hips $419,567 299 payments
  3. TRIATHLON $46,693 25 payments
  4. INSIGNIA $38,986 24 payments
  5. ACCOLADE $23,913 14 payments
  6. TRIDENT $21,288 10 payments
  7. RESTORATION $20,831 6 payments
  8. EXETER Hips $20,167 5 payments
  9. EXETER Hips $15,495 14 payments
  10. MAKO Joint Replacement Hips, Knees $15,065 13 payments
  11. Other $22,338 53 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 2 drugs

Part D claims

93

Median for Orthopedic Surgery: 203

Drug cost

$179

Median for Orthopedic Surgery: $1,433

Branded share of claims

0%

Median for Orthopedic Surgery: 11.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Amoxicillin Generic 80 $120
Cephalexin Generic 13 $59

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 18,934 Part D prescribers listed as Orthopedic Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 43 billing codes

Paid by Medicare

$227,737

Of which drugs: $3,375

Medicare patients

271

Average age 75

Services billed

17,340

170 women, 101 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
Arthritis 75%
High blood pressure 60%
Ischemic heart disease 22%
Cancer 18%
Depression 16%
Osteoporosis 15%
Diabetes 12%
Atrial fibrillation 12%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Injection, triamcinolone acetonide, not otherwise specified, 10 mg J3301 Office 47 480 $346
Injection, bupivicaine, not otherwise specified, 0.5 mg J0665 Office 42 15,323 $150

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

1,036 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Orthopaedic Surgery in Washington

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record